Irish equine tech company set to launch in US market
Published 14/10/2015 | 02:30
Equilume, the University College Dublin (UCD) equine technology spin-out company, is about to tap into the lucrative US thoroughbred and quarterhorse market with the Equilume Light Mask.
Produced in Ireland, the mask has been scientifically proven to provide the optimum level of blue light to a single eye of a mare to successfully advance her breeding season, prevent long gestations and ensure reproductive activity in early foaling mares.
It is already proving hugely successful for breeders throughout Europe and it is hoped that it will soon take off in the US with the recent expansion of its sales and marketing team.
Equilume, with headquarters in Co Kildare, now employs nine people in Ireland. In addition, the company engages over 15 sales agents and representatives at locations around the world.
Peter Brady, CEO of Equilume, said: "Our new sales and marketing executives, Christopher Farrell and Avril Dunne, both UCD Animal Science-Equine graduates, will focus on the thoroughbred market in the Kentucky Bluegrass and the American quarter horse market in Texas, Oklahoma and California. Jean Scally has also joined the team to help build our brand and commercial marketing expertise as we expand our international sales."
Breeders around the world are using the Equilume Light Mask to eliminate the requirement to maintain their non-pregnant mares indoors under artificial lighting and thereby save at least €1,000 per mare per season while at the same meeting crucial industry timelines. The technology is also being successfully used globally to help pregnant mares foal on time while optimising foal birth weights.
The Equilume Light Mask has been developed as a result of ground-breaking research carried out by Dr Barbara Murphy in UCD's School of Agriculture and Food Science, in collaboration with Professor John Sheridan, an optoelectronics researcher in UCD's School of Electrical and Electronic Engineering.
Last year the company secured €550,000 in seed funding from Enterprise Ireland and a number of angel investors based here and abroad.